DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
Fibrinogen Amyloidosis
In patient news, I know of one patient who had a combined liver and kidney transplant in 2018, and as I mentioned in the previous blog post, the third liver-only transplant for fibrinogen amyloidosis occurred in December. The use of liver-only transplants for fibrinogen amyloidosis is being covered more in the medical literature now, so that is good news. Speaking of good news, I continue to get my annual physical exam and I am still asymptomatic.
Related Content
-
educationHereditary Fibrinogen Aα-Chain AmyloidosisAmyloidosis is a rare disease caused by ...
-
educationMacroglossia in Light-Chain AmyloidosisA 78-year-old man presented to the emerg...
-
videos & visualsQ&A Discussion Panel With Drs. Gertz, D’Souza, Rosenbaum & Chakraborty – ASG Webinar – 3...https://www.youtube.com/watch?v=vP4wvJq5...
-
videos & visuals¿Qué es la Amiloidosis hereditaria por Transtiretina?https://www.youtube.com/watch?v=MSr2Y2Hl...
-
educationObesity is a Significant Susceptibility Factor for Idiopathic AA AmyloidosisBackground: To investigate obesity as s...
-
educationTherapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisThe liver has become an increasingly int...
-
videos & visualsATTR Amyloidosis: Current and Emerging Therapies by Dr. Melissa Lyle – ASG Webinar 7.15.23 – 2/7https://www.youtube.com/watch?v=UcxmPgZ7...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.